Clinical trials: sponsored by M.D. Anderson Cancer Center
Lymphoma, Mantle-Cell
Study Of Yttrium-ibritumomab (Zevalin) For the Treatment Of Patients With Relapsed And Refractory Mantle Cell Lymphoma
Study of Yttrium-ibritumomab (Zevalin) For the treatment of Patients with Relapsed \& Refractory Mantle Cell Lymphoma
- Trial name
- NCT00038623
- Testing
- Yttrium-ibritumomab (Zevalin), Rituximab
- Where
- United States
- Volunteers
- 35 people, healthy volunteers welcome
- Sponsor
- M.D. Anderson Cancer Center
Advanced Cancer
Patient-Reported Outcomes (PRO)-Based Palliative and Hospice Care Practice: A Qualitative Study
The goal of this research study is to collect information to plan how to design a computer program for cancer patients receiving palliative care, their caregivers, and doctors and nurses who work in palliative care.
- Trial name
- NCT00878267
- Testing
- Interview
- Where
- United States
- Volunteers
- 9 people, healthy volunteers welcome
- Sponsor
- M.D. Anderson Cancer Center